A Phase 1 Study of ARN-6039

Clinical trial NCT03237832 · COMPLETED

Trial details

NCT number: NCT03237832
Sponsor: Arrien Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2016-05-16
Primary completion: 2016-10-06
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.